NCT00641615View on ClinicalTrials.gov

Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

RNF43-721

Doses of 0.5mg, 1.0mg, 3.0mg/body/week

Trial Locations (1)

116-8567

Tokyo Women's Medical University Medical Center East, Tokyo

All Listed Sponsors
collaborator

Human Genome Center, Institute of Medical Science, University of Tokyo

OTHER

lead

Kazuhiko Yoshimatsu

OTHER

NCT00641615 - Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter